Capital Goods · NSE: AXISCADES
AXISCADES Technologies
Q2 FY27 earnings highlights, from the results presentation
Q2 FY27 · From the investor presentation
- M.Cap
- ₹7,881Cr
- P/E
- -289.0×
- 1Y return
- +18.96%
- From 52W high
- −21.5%
Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.
Share price
Results Q2 FY27, as filed · consolidated · ₹ Cr
| Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ | |
|---|---|---|---|---|---|
| Revenue | 196 | 299 | -34.6% | 183 | +6.7% |
| EBITDA | 6 | 47 | -86.7% | 9 | -27.8% |
| EBITDA margin | 3.2% | 15.7% | -1253 bps | 4.7% | -153 bps |
| One-off items | -38 | — | — | — | — |
| PBTProfit before tax | -52 | 36 | -244.4% | -6 | — |
| Net profit | 47 | 23 | +104.8% | -15 | — |
| EPS (₹) | 10.85 | 5.36 | +102.4% | -3.49 | — |
From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.
Guidance
More figures from the presentation
“Planned acquisitions may be delayed by ~3 months; interim funding will be”
In short
- 01Phase 1 of the US$237 million divestment closed on 30 September 2026, with a ₹140.84 Cr gain in Q2 FY27.
- 02Phase 2 proceeds now expected in February 2027, moved from end-November; planned acquisitions may slip about 3 months.
- 03Q2 FY27 reported PAT was about ₹47.3 Cr including exceptional items; normalised PBT was ₹3.7 Cr.
- 04One-time non-cash write-offs of about ₹58.3 Cr were taken in Q2 FY27 for Add Solutions, legacy holdings and Epcogen.
- 05From Q3 FY27, ESOP charge seen at about ₹6 Cr a quarter, corporate overheads about ₹12 Cr, legal costs ₹4-5 Cr.
- 06XIDA, Defence and Aerospace each planned to run at about 20% division EBITDA margin from Q3 FY27.
- 0716 new defence orders worth ₹80.3 Cr since Q1 results, with about ₹730 Cr production potential.
- 08Power 930 aspiration of ₹9,000 Cr revenue and ₹960 Cr PAT by FY2030, stated as not guidance; FY27 revenue intended to equal or exceed FY26.
Capex
Order book
Defence: 16 new defence orders of ₹80.3 Cr since Q1 results; about ₹730 Cr production potential
Slides · p. 21
Defence: 16 new defence orders of ₹80.3 Cr since Q1 results; about ₹730 Cr production potential
“16 new orders, ₹80.3 Cr, since Q1 results; ~₹730 Cr production potential added.”
Defence: Q1 FY27 programme wins added ₹332 Cr to assured forecast visibility
Slides · p. 9
Defence: Q1 FY27 programme wins added ₹332 Cr to assured forecast visibility
“+₹332 Cr to assured forecast visibility”
Segments
XIDA: XIDA restructuring scheduled to complete in Q3 FY27; ~300 engineers moving to India entity
Slides · p. 10
XIDA: XIDA restructuring scheduled to complete in Q3 FY27; ~300 engineers moving to India entity
“incorporated, with ~300 engineers transferring into the entity. The restructuring is scheduled to complete in Q3 FY27.”
Space: Space revenue expected to build from Q2 FY28; DAC space facility being prepared
Slides · p. 20
Space: Space revenue expected to build from Q2 FY28; DAC space facility being prepared
“Status: the space facility at DAC is being prepared and the partnerships are in place. Revenue is expected to build from Q2 FY28.”
Aerospace: Cloud Wave Q2 FY27 revenue ₹16.5 Cr at 20.3% EBITDA margin
Slides · p. 11
Aerospace: Cloud Wave Q2 FY27 revenue ₹16.5 Cr at 20.3% EBITDA margin
“₹16.5 Cr of revenue at a 20.3% EBITDA margin in Q2 FY27, towards a single integrated manufacturing campus”
Defence, XIDA: Defence and XIDA grew H1 revenue by 46% and 55%
Slides · p. 7
Defence, XIDA: Defence and XIDA grew H1 revenue by 46% and 55%
“Defence and XIDA grew H1 revenue by 46% and 55%.”
Defence: Defence Q2 EBITDA margin 17.6% on ₹127.7 Cr revenue
Slides · p. 9
Defence: Defence Q2 EBITDA margin 17.6% on ₹127.7 Cr revenue
“17.6% margin on ₹127.7 Cr revenue”
Margins and costs
ESOP charge of ₹12 Cr in Q2 FY27; about ₹6 Cr a quarter from Q3 FY27
Slides · p. 13
ESOP charge of ₹12 Cr in Q2 FY27; about ₹6 Cr a quarter from Q3 FY27
“Charge of ₹12 Cr recognised in Q2 FY27; about ₹6 Cr a quarter from Q3 FY27.”
Cost reset ahead of Phase 2; corporate overheads of about ₹12 Cr a quarter
Slides · p. 8
Cost reset ahead of Phase 2; corporate overheads of about ₹12 Cr a quarter
“Cost reset ahead of the Phase 2 closing; corporate overheads of ~₹12 Cr a”
Legal and professional costs: normal run-rate ₹4-5 Cr a quarter, down at least ₹5 Cr
Slides · p. 8
Legal and professional costs: normal run-rate ₹4-5 Cr a quarter, down at least ₹5 Cr
“Normal run-rate ₹4–5 Cr a quarter; down by at least ₹5 Cr a quarter as the work”
Space: Space cost of ₹2 Cr per quarter, part of corporate overheads
Slides · p. 20
Space: Space cost of ₹2 Cr per quarter, part of corporate overheads
“₹2 Cr per quarter”
Recovery to come from lower corporate costs, halving ESOP charge and normalising legal costs
Slides · p. 8
Recovery to come from lower corporate costs, halving ESOP charge and normalising legal costs
“With all three business units profitable, recovery comes from a lower corporate cost base, the ESOP charge halving, legal costs”
Debt and working capital
Net borrowing of ₹310.0 Cr in H1 funded Cloud Wave and capex
Slides · p. 12
Net borrowing of ₹310.0 Cr in H1 funded Cloud Wave and capex
“net borrowing of ₹310.0 Cr funded Cloud Wave and capex.”
H1 FY27 operating cash outflow of ₹57.7 Cr vs ₹13.6 Cr inflow in H1 FY26
Slides · p. 12
H1 FY27 operating cash outflow of ₹57.7 Cr vs ₹13.6 Cr inflow in H1 FY26
“H1 FY27 operating cash flow was ₹(57.7) Cr (H1 FY26: ₹13.6 Cr), as working capital”
Divestment proceeds give means to reduce debt
Slides · p. 5
Divestment proceeds give means to reduce debt
“closed, we have the means to reduce debt, align”
H1 FY27 finance costs ₹21.9 Cr vs ₹13.9 Cr, up 57.9%
Slides · p. 14
H1 FY27 finance costs ₹21.9 Cr vs ₹13.9 Cr, up 57.9%
“Finance costs 21.9 13.9 +57.9%”
Total assets up 42% to ₹2,079.7 Cr at 30 September 2026
Slides · p. 17
Total assets up 42% to ₹2,079.7 Cr at 30 September 2026
“Balance Sheet: Assets Up 42% to ₹2,079.7 Cr”
Acquisitions and new business
US$237 million Phase 1 divestment closed on 30 September 2026
Slides · p. 12
US$237 million Phase 1 divestment closed on 30 September 2026
“The US$237 million Phase 1 divestment closed on 30 September 2026.”
Divestment proceeds now expected in February 2027, previously end-November
Slides · p. 21
Divestment proceeds now expected in February 2027, previously end-November
“Proceeds expected in February 2027 (previously end-November).”
XIDA: XIDA plans selective acquisitions in physical AI and semiconductors
Slides · p. 10
XIDA: XIDA plans selective acquisitions in physical AI and semiconductors
“acquisitions in physical AI and semiconductors. Any transaction will be”
Space: Space partnerships in place with U-Space and Aldoria
Slides · p. 21
Space: Space partnerships in place with U-Space and Aldoria
“Partnerships in place with U-Space (satellite buses) and Aldoria (space situational awareness);”
Aerospace: Cloud Wave (90% stake) closed and consolidated from Q2 FY27
Slides · p. 21
Aerospace: Cloud Wave (90% stake) closed and consolidated from Q2 FY27
“Cloud Wave (90% stake) closed and consolidated from Q2 FY27, and was earnings-accretive in its first”
Management
Leadership, finance and facility base for the plan through FY28 in place
Slides · p. 21
Leadership, finance and facility base for the plan through FY28 in place
“The leadership, finance and facility base required to support the plan through FY28 is in place.”
One-offs
Total exceptional write-offs of about ₹58.3 Cr in Q2 FY27
Slides · p. 6
Total exceptional write-offs of about ₹58.3 Cr in Q2 FY27
“Total exceptional write-offs in Q2 FY27: ~₹58.3 Cr (₹38.4 Cr impairment in continuing operations plus ₹19.9”
Impairment of ₹38.4 Cr for Add Solutions and legacy holdings
Slides · p. 6
Impairment of ₹38.4 Cr for Add Solutions and legacy holdings
“Impairment: ₹38.4 Cr (Add Solutions and legacy holdings)”
Remaining Epcogen goodwill of ₹19.9 Cr written off in Q2 FY27
Slides · p. 6
Remaining Epcogen goodwill of ₹19.9 Cr written off in Q2 FY27
“remaining goodwill of ₹19.9 Cr has been written off in Q2 FY27.”
Exceptional gain of ₹140.84 Cr on Phase 1 disposal in Q2 FY27
Slides · p. 6
Exceptional gain of ₹140.84 Cr on Phase 1 disposal in Q2 FY27
“Exceptional gain in Q2 FY27: ₹140.84 Cr on the Phase 1 disposal, including ₹20.94 Cr FCTR recycled and”
₹13.5 Cr of receivable provisions in H1, ₹9.6 Cr of them one-time Q1 items
Slides · p. 14
₹13.5 Cr of receivable provisions in H1, ₹9.6 Cr of them one-time Q1 items
“₹13.5 Cr of receivable provisions (₹9.6 Cr of them”
Other
Q2 FY27 reported PAT about ₹47.3 Cr incl. exceptional items, vs ₹23.1 Cr in Q2 FY26
Slides · p. 13
Q2 FY27 reported PAT about ₹47.3 Cr incl. exceptional items, vs ₹23.1 Cr in Q2 FY26
“Reported PAT, including exceptional items ~₹47.3 Cr About double the ₹23.1 Cr of Q2 FY26; Q1 FY27 was a loss of ₹(14.8) Cr.”
Q2 FY27 EBITDA before ESOP ₹23.4 Cr and normalised PBT ₹3.7 Cr
Slides · p. 8
Q2 FY27 EBITDA before ESOP ₹23.4 Cr and normalised PBT ₹3.7 Cr
“Before ESOP and one-time items, Q2 FY27 was profitable: EBITDA before ESOP ₹23.4 Cr and normalised PBT ₹3.7 Cr, while revenue”
Retained business: H1 retained revenue ₹378.9 Cr, up 55%; Q2 retained revenue up 30%
Slides · p. 2
Retained business: H1 retained revenue ₹378.9 Cr, up 55%; Q2 retained revenue up 30%
“H1 retained revenue ₹378.9 Cr, +55% YoY · Q2 retained revenue +30% YoY”
Retained business: Retained revenue now 54% of group in H1 FY27, vs 45% a year ago
Slides · p. 12
Retained business: Retained revenue now 54% of group in H1 FY27, vs 45% a year ago
“H1 FY27 retained revenue is now 54% of the group (H1 FY26: 45%) and grew 55% year on year.”
Of nine commitments, four delivered, four on course, one revised
Slides · p. 21
Of nine commitments, four delivered, four on course, one revised
“Of nine commitments, four delivered and four on course — and one has been revised. Power 930 remains on course. No commitment has been withdrawn.”
Sources
- Investor presentation, Q2 FY27 Filed 13 Nov 2026 · 22 pages
Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

